[Elekta’s PR] Elekta announces Exclusive Agreement with DOSIsoft for Distribution of Key Patient Specific QA Solutions
- September 5, 2019
Products fill out company’s Elekta Assurance portfolio for comprehensive end-to-end quality assurance.
QA customer centers in expansion worldwide
- June 26, 2019
An increasing number of RT hospital centers in the world have adopted DOSIsoft’s Patient Quality Assurance (QA) software to optimize their patient QA processus and improve patient safety.
[HCB News] Software Innovations for Patient-specific Theranostics and Molecular Radiotherapy
- June 25, 2019
Molecular radiotherapy (MRT) is a promising and quickly expanding set of therapeutic options for treating many cancer cases, including cases where conventional techniques are unsuccessful. Cancer cases have been treated with radiopharmaceuticals since the 1940s, but the number and range of radiotherapeutics on the market have recently expanded significantly. Discover how software technologies innovate Theranostics and Molecular Radiotherapy in a patient-specific approach.
[PhD Thesis] Relation dose-effet et optimisation de la dosimétrie en radiothérapie interne sélective du carcinome hépatocellulaire*
- June 13, 2019
*Dose-effect relationship and dosimetry optimization for selective internal radiation therapy of hepatocellular carcinoma
Work in collaboration with CHU de Montpellier
PhD Thesis completed on June 3rd 2019 by Marilyne Kafrouni
DOSIsoft: project member of MRT dosimetry
- May 21, 2019
DOSIsoft participated in the joint research project (JRP) on Metrology for clinical implementation of dosimetry in molecular radiotherapy (MRTDosimetry) since June 2016. During three years, DOSIsoft shared its practical expertise and industrial visions in nuclear medicine research and contributed to the discussion on the problem of determining the radiation dose to individual patients who are undergoing MRT.
[AuntMinnie.com] DOSIsoft wins FDA nod for PLANET Onco Dose software
- March 15, 2019
Radiation oncology and nuclear medicine software developer DOSIsoft has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its Planet Onco Dose software for molecular imaging and molecular radiotherapy dosimetry applications.
Léon Bérard Center has selected EPIbeam, The EPID-based pretreatment patient-specific Quality Assurance software solution from DOSIsoft
- February 6, 2019
DOSIsoft announces that the Léon Bérard Center (CLB, Lyon, France), has selected EPIbeam – its Patient Specific Quality Assurance (QA) Software based on the Electronic Portal Imaging Device (EPID) and dedicated to pretreatment verification of irradiation beams.
World Cancer Day 2019: I AM DOSISOFT AND I WILL INNOVATE
- February 4, 2019
Like every year, on February 4th, DOSIsoft gets involved in the World Cancer Day (WCD)
DOSIsoft counts 200 customer centers in 26 countries
- January 17, 2019
More than 200 customer centers in 26 countries trust DOSIsoft. Let’s start 2019 with a warm welcome to our new users adopting Patient Specific Quality Assurance & Molecular RadioTherapy Solutions
New Year 2019: Upgraded versions EPIbeam & EPIgray®
- January 7, 2019
DOSIsoft presents you the upgraded versions of EPIbeam 184.108.40.206 & EPIgray® 220.127.116.11 at the beginning of the New Year 2019…